XML 75 R57.htm IDEA: XBRL DOCUMENT v3.24.3
Segment Data - Financial Information for Company's Segments (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2022
Segment Reporting Information [Line Items]      
Integration, restructuring and transaction expense $ (458) $ (313) $ (192)
Income from Continuing Operations Before Income Taxes 2,005 1,662 1,783
Total Capital Expenditures 725 874 973
Total Depreciation and Amortization 2,286 2,288 2,229
Operating Segments      
Segment Reporting Information [Line Items]      
Income from Continuing Operations Before Income Taxes 5,758 4,769 5,006
Operating Segments | Medical      
Segment Reporting Information [Line Items]      
Income from Continuing Operations Before Income Taxes 2,742 1,967 2,215
Total Capital Expenditures 438 563 602
Total Depreciation and Amortization 1,216 1,199 1,144
Operating Segments | Life Sciences      
Segment Reporting Information [Line Items]      
Income from Continuing Operations Before Income Taxes 1,595 1,585 1,710
Total Capital Expenditures 114 139 213
Total Depreciation and Amortization 272 277 283
Operating Segments | Interventional      
Segment Reporting Information [Line Items]      
Income from Continuing Operations Before Income Taxes 1,420 1,217 1,081
Total Capital Expenditures 127 138 130
Total Depreciation and Amortization 786 799 789
Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment      
Segment Reporting Information [Line Items]      
Integration, restructuring and transaction expense (458) (313) (173)
Net interest expense (364) (403) (382)
Corporate and All Other      
Segment Reporting Information [Line Items]      
Income from Continuing Operations Before Income Taxes (2,931) (2,391) (2,668)
Total Capital Expenditures 46 35 28
Total Depreciation and Amortization $ 13 $ 13 $ 13